You are invited…
Managing the Hypertension Patient: is there a role for renal denervation?
| Friday 13:05 - 13:50 | Speaker | |
|---|---|---|
| Latest Data on Radiofrequency Renal Denervation | Prof. Flavio Ribichini | |
| Answering Key Questions: What do we know about safety, durability and high-risk patients? | Prof. Flavio Ribichini Dr. Jose Antonio Garcia-Donaire |
|
| Guideline Evolution: Current recommendations for renal denervation | Dr. Jose Antonio Garcia-Donaire | |
| Should RDN be an option for CKD patients? | Prof. Jose Antonio-Donaire | |
| Discussion: Renal Denervation in the treatment pathway of hypertension | Prof. Flavio Ribichini Dr. Jose Antonio Garcia-Donaire |
Hosted by:
The new patient journey: Current and future management approaches to SHPT and CKD-aP
| Saturday - 12:35 - 13:20 | Speaker | |
|---|---|---|
| Extended-release calcifediol (ERC) in patients with non-dialysis-dependent CKD: A new answer to an old dilemma | Prof. James Wetmore, USA | |
| New frontiers for dialysis patients with CKD-associated pruritus: addressing unmet needs with difelikefalin (DFK) | Prof. Juan Buades, Spain |
Hosted by:
Date of preparation: September 2021
HQ-DFK-2100150
